Strong Sales Growth

Smith & Nephew Plc 3 April 2002 3 April 2002 SMITH & NEPHEW PLC STRONG SALES GROWTH CONTINUES FOR SMITH & NEPHEW Smith & Nephew, the advanced medical devices group, has seen sales growth in the first quarter of 2002 continue at the strong level achieved during 2001, Chairman Dudley Eustace told shareholders at the company's AGM today. Mr Eustace said that Smith & Nephew's chosen markets are growing robustly. 'We are well positioned to benefit from the increasing demand for easier-to-use, more efficient products, and intend to maintain the momentum we have developed in recent years. Our emphasis on achieving strong organic growth will continue by increasing our sales teams, running our businesses more efficiently, and ensuring we maintain the pace of launching innovative new products. We will also seek to acquire businesses or technologies which strengthen our long-term prospects and underpin our drive for shareholder value.' He said that in 2001 the group's three major businesses all improved their sales and profit performance. Orthopaedics maintained its position as one of the fastest growing orthopaedics companies, growing at almost twice the market rate. Endoscopy reinforced its position as world No 1 in minimally invasive surgery of the joints, with the knee ligament repair business growing by 15%. Wound Management consolidated its position as world leader in the advanced treatment of hard to heal wounds, integrating two significant acquisitions. Enquiries: Chris O'Donnell, Chief Executive Tel: +44 (0) 20 7401 7646 Smith & Nephew plc Peter Hooley, Finance Director Tel: +44 (0) 20 7401 7646 Smith & Nephew plc Margaret Stewart, Group Director, Corporate Affairs Tel: +44 (0) 20 7401 7646 Smith & Nephew plc David Yates Tel: +44 (0) 20 7831 3113 Financial Dynamics This information is provided by RNS The company news service from the London Stock Exchange
UK 100